Kale for Anti-Inflammatory

Research suggests that kale and its bioactive compounds — including kaempferol, sulforaphane, glucosinolates, isothiocyanates, and anthocyanins — demonstrate anti-inflammatory properties across a range of laboratory, animal, and limited human studies. The evidence base consists primarily of in vitro cell studies, mouse models, and reviews of preclinical findings, with one small randomized controlled trial (20 participants) reporting that an anthocyanin-rich kale extract performed comparably to ibuprofen for post-surgical inflammation, and a topical skincare study showing reduced inflammatory markers in people with eczema. Studies indicate that these compounds may work through multiple pathways, including suppressing pro-inflammatory signaling molecules such as IL-1β, IL-6, COX-2, and iNOS, modulating gut microbiota composition, and reinforcing protective barriers in skin and gut tissue. However, the overall body of evidence remains heavily weighted toward preclinical models, several included studies examine kale compounds in combination with other plant extracts rather than in isolation, and the human trials are too small to draw firm conclusions — meaning that while the direction of findings is broadly supportive, considerably more clinical research would be needed before the strength of these effects in humans can be confidently characterized.